Kura Oncology Inc. (KURA)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
7.39
0.13 (1.79%)
At close: Jan 15, 2025, 10:45 AM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 849.00K | 759.00K | 558.00K | 194.00K | n/a | 10.00K | 30.00K | 31.00K | 20.00K | 23.91K | 22.73K | 22.34K | 23.44K | 20.51K | 19.16K | n/a |
Gross Profit | -849.00K | -759.00K | -558.00K | -194.00K | n/a | -10.00K | -30.00K | -31.00K | -20.00K | -23.91K | -22.73K | -22.34K | -23.44K | -20.51K | -19.16K | n/a |
Operating Income | -165.80M | -140.62M | -131.82M | -92.09M | -67.48M | -62.88M | -36.08M | -28.37M | -23.86M | -11.80M | -22.34K | -23.44K | -20.51K | -41.02K | -38.32K | -33.62K |
Interest Income | 14.72M | 4.25M | 1.21M | 2.80M | 4.67M | 3.17M | 751.00K | 499.00K | 128.00K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -152.63M | -135.84M | -130.47M | -89.63M | -63.14M | -60.45M | -35.43M | -27.56M | -22.63M | -11.01M | -27.32K | -27.04K | -22.39K | -22.39K | -20.00K | -33.62K |
Net Income | -152.63M | -136.07M | -129.91M | -89.43M | -63.14M | -60.45M | -35.43M | -27.56M | -22.63M | -11.01M | -27.32K | -27.04K | -22.39K | -22.39K | -20.00K | -33.62K |
Selling & General & Admin | 50.57M | 47.05M | 46.54M | 31.50M | 19.65M | 16.10M | 9.65M | 7.96M | 6.09M | 3.85M | 22.34K | 23.44K | 20.51K | 20.51K | 19.16K | n/a |
Research & Development | 115.23M | 92.81M | 84.72M | 60.40M | 47.83M | 46.79M | 26.43M | 20.40M | 17.78M | 8.05M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | n/a | 4.03M | 792.00K | 2.27M | 4.34M | 2.44M | 643.00K | 807.00K | 1.24M | 2.00M | n/a | n/a | n/a | n/a | n/a | -33.62K |
Operating Expenses | 165.80M | 139.87M | 131.26M | 91.90M | 67.48M | 62.88M | 36.08M | 28.37M | 23.86M | 10.90M | 22.34K | 23.44K | 20.51K | 20.51K | 19.16K | -33.62K |
Interest Expense | 1.55M | 229.00K | 414.00K | 578.00K | 580.00K | 970.00K | 888.00K | 577.00K | 88.00K | 5.88K | 4.97K | 3.60K | 1.89K | 1.89K | 838.00 | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 165.80M | 139.87M | 131.26M | 91.90M | 67.48M | 62.88M | 36.08M | 28.37M | 23.86M | 10.90M | 22.34K | 23.44K | 20.51K | 41.02K | 38.32K | -33.62K |
Income Tax | n/a | 229.00K | -558.00K | -194.00K | -10 | 3.41M | -30.00K | -31.00K | -20.00K | 268.88K | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 73.23M | 66.99M | 66.35M | 53.08M | 41.95M | 35.19M | 23.24M | 18.70M | 9.93M | 141.00K | 5.00M | 5.00M | 5.00M | 5.00M | 5.00M | n/a |
Shares Outstanding (Diluted) | 73.23M | 66.99M | 66.35M | 53.08M | 41.95M | 35.19M | 23.24M | 18.70M | 9.93M | 141.00K | 5.00M | 5.00M | 5.00M | 5.00M | 5.00M | n/a |
EPS (Basic) | -2.08 | -2.03 | -1.96 | -1.68 | -1.51 | -1.72 | -1.52 | -1.47 | -2.28 | -78.11 | -0.01 | -0.01 | -0.00 | -0.00 | -0.00 | n/a |
EPS (Diluted) | -2.08 | -2.03 | -1.96 | -1.68 | -1.51 | -1.72 | -1.52 | -1.47 | -2.28 | -78.11 | -0.01 | -0.01 | -0.00 | -0.00 | -0.00 | n/a |
EBITDA | -164.96M | -139.11M | -129.71M | -91.70M | -67.48M | -62.87M | -36.05M | -28.34M | -23.84M | -11.80M | -22.34K | -23.44K | -20.51K | -41.02K | -38.32K | -33.62K |
Depreciation & Amortization | 849.00K | 759.00K | 558.00K | 194.00K | 10.00K | 10.00K | 30.00K | 31.00K | 20.00K | 3.00K | n/a | n/a | n/a | n/a | n/a | n/a |